Horan Securities’s Idexx Laboratories IDXX Stock Holding History

Horan Securities’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6	Closed	-$2K	–	682
2022 Q2	$2K	Buy	+6	New	+$2.45K	﹤0.01%	550

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Horan Securities's IDXX Position: Q3 2022 in Review

Horan Securities sold out of Idexx Laboratories (IDXX) in Q3 2022, closing a stake of 6 shares — an estimated $2K sold.

Horan Securities first reported a position in IDXX in Q2 2022 and held it in 1 quarter. The position peaked at $2K in Q2 2022. 922 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

Horan Securities reported no remaining Idexx Laboratories position as of Q3 2022 after selling out during the quarter.
Horan Securities sold 6 Idexx Laboratories shares in Q3 2022, an estimated $2K.
Horan Securities first reported a position in Idexx Laboratories in Q2 2022 and held it in 1 quarter.
Horan Securities's Idexx Laboratories position peaked at $2K in Q2 2022.
922 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on Horan Securities's 13F filing for Q3 2022, filed 12 Oct 2022.